Gil Breiman, Partner, Chair, International Practice, Co-Chair, Venture Capital & Emerging Companies
Gil Breiman is actively involved with the innovation ecosystem, representing investors and entrepreneurs launching, growing, and exiting innovative businesses in a broad spectrum of high technology and life sciences fields. He regularly advises clients on international expansion in establishing and expanding overseas business. As co-chair of the firm’s Venture Capital & Emerging Companies Group, Gil represents entrepreneurs, corporations, and investors in all phases of the business cycle, from incorporation to financing (angel, strategic, non-dilutive, venture capital), to business development and growth. As chair of the firm’s international practice, Gil has represented numerous companies and individuals from various countries in cross-border transactions, mergers and acquisitions, sales channel setups, and operations.
He represents groups that finance and acquire commercial real estate buildings and related assets. Those financings involve various complex international and U.S. structuring and financing matters. Gil also represents and advises sellers and buyers of medical practices, helping medical professionals in business transitions, expansions, and ongoing business matters. He has extensive experience representing companies and individuals engaging in business between the U.S. and Israel, and has represented government agencies in America.